SML3242
MR6-31-2
≥98% (HPLC)
别名:
2-(4-Chlorobenzyl)benzo[d][1,2]selenazol-3(2H)-one, 2-[(4-Chlorophenyl)methyl]-1,2-benzisoselenazol-3(2H)-one
InChI
1S/C14H10ClNOSe/c15-11-7-5-10(6-8-11)9-16-14(17)12-3-1-2-4-13(12)18-16/h1-8H,9H2
InChI key
XZWKXIFLMYRVTK-UHFFFAOYSA-N
SMILES string
O=C1N(CC2=CC=C(Cl)C=C2)[Se]C3=CC=CC=C31
assay
≥98% (HPLC)
form
powder
color
white to beige
storage temp.
2-8°C
Quality Level
Biochem/physiol Actions
CNS penetrant potent inhibitor of SARS-CoV-2 Mpro that bind at the Mpro catalytic site
MR6-31-2, a CNS penetrant ebselen analog, is a potent inhibitor of SARS-CoV-2 Mpro that bind at the Mpro catalytic site. MR6-31-2 donates a selenium atom, forming a covalent bond and blocking the histidine-Cys catalytic dyad. It exhibits good neuroprotective effects and low cytotoxicity in cell-based and mouse models of motor neuron disease. MR6-31-2 covalently binds to A4V superoxide dismutase-1 (SOD1) and promotes its thermal stability.
wgk
WGK 3
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - STOT RE 2
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
法规信息
新产品
此项目有
Kangsa Amporndanai et al.
Nature communications, 12(1), 3061-3061 (2021-05-26)
The SARS-CoV-2 pandemic has triggered global efforts to develop therapeutics. The main protease of SARS-CoV-2 (Mpro), critical for viral replication, is a key target for therapeutic development. An organoselenium drug called ebselen has been demonstrated to have potent Mpro inhibition and
Varunya Chantadul et al.
Communications biology, 3(1), 97-97 (2020-03-07)
Mutations to the gene encoding superoxide dismutase-1 (SOD1) were the first genetic elements discovered that cause motor neuron disease (MND). These mutations result in compromised SOD1 dimer stability, with one of the severest and most common mutations Ala4Val (A4V) displaying
Kangsa Amporndanai et al.
Nature communications, 12(1), 3061-3061 (2021-05-26)
The SARS-CoV-2 pandemic has triggered global efforts to develop therapeutics. The main protease of SARS-CoV-2 (Mpro), critical for viral replication, is a key target for therapeutic development. An organoselenium drug called ebselen has been demonstrated to have potent Mpro inhibition and
Varunya Chantadul et al.
Communications biology, 3(1), 97-97 (2020-03-07)
Mutations to the gene encoding superoxide dismutase-1 (SOD1) were the first genetic elements discovered that cause motor neuron disease (MND). These mutations result in compromised SOD1 dimer stability, with one of the severest and most common mutations Ala4Val (A4V) displaying
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持